Useful stroke trials left unpublished

Apr 22, 2010

An investigation into unpublished stroke research data has revealed that 19.6% of completed clinical trials, which could potentially influence patient care, are not published in full. Researchers writing in BioMed Central's open access journal Trials describe how these unpublished studies included more than 16,000 participants and tested 89 different interventions.

Peter Sandercock and his colleague Lorna Gibson worked with a team of researchers from the University of Edinburgh, UK, to search the Cochrane Group's Specialised Register of Trials for completed trials of pharmacological interventions for , and to determine how many of these were ultimately published. He said, "Failure to publish trial data is to be deprecated as it sets aside the of participants' consent to be exposed to the risks of experimental interventions, potentially biases the assessment of the effects of therapies, and may lead to premature discontinuation of research into promising treatments".

The researchers identified 940 trials, of which 125 were not published in full. The largest trial included 856 patients, while two unpublished trials included fewer than 10 patients each. According to Sandercock, "Several of the trials we identified may have been large enough to influence clinical practice and the findings of systematic reviews and meta-analyses".

Sandercock concludes, "Well designed clinical trials should be published because their results can benefit patients, justifying the risk to trial participants from experimental treatments. We found 22 unpublished trials that reported the number of deaths. In these trials, 636 people died, but no information was available on whether the had contributed to any of those deaths".

551 different researchers were involved in conducting these studies and of these, 72 had been involved in more than one trial that remained unpublished.

Explore further: Allergan to cut 1,500 employees in restructuring (Update)

More information: A systematic review of clinical trials of pharmacological interventions for acute ischaemic stroke (1955-2008) that were completed, but not published in full, Lorna M Gibson, Miriam Brazzelli, Brenda M Thomas and Peter AG Sandercock, Trials 2010, 11:43. doi:10.1186/1745-6215-11-43

add to favorites email to friend print save as pdf

Related Stories

Half of trials supporting FDA applications go unpublished

Sep 23, 2008

Over half of all supporting trials for FDA-approved drugs remained unpublished 5 years after approval, says new research published in this week's PLoS Medicine. The most important trials determining efficacy, and those with s ...

Just how useful are animal studies to human health?

Dec 15, 2006

Animal studies are of limited usefulness to human health because they are of poor quality and their results often conflict with human trials, argue researchers in a study on bmj.com today.

Recommended for you

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

Safety problems at US germ labs acknowledged

Jul 16, 2014

(AP)—The director of the U.S. Centers for Disease Control and Prevention acknowledged Wednesday that systemic safety problems have for years plagued federal public health laboratories that handle dangerous ...

User comments : 0